Skip to main
CELL
CELL logo

PhenomeX Inc (CELL)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy PhenomeX Inc (CELL) Stock

About PhenomeX Inc (CELL)

Bruker Cellular Analysis, Inc. is a biology company that engages in the study of cells. Its tools and services allow the prevention and treatment of disease. The company was founded in 2011 and is headquartered in Emeryville, CA.
Market cap$98.79M
Today's volume
Revenue (TTM)
Avg. daily volume1.45M
EBITDA (TTM)
Open
Price / earnings ratio-0.65x
Today's range
Debt / equity
52 week range$0.38 - $3.65
5 year debt / equity20.53x
Beta (LTM)1.49x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earningsAug 14, 2023
Dividend payable date

Frequently Asked Questions (FAQ)

As of Jul 15, 2025, the market cap for CELL stock is $98.8M

The current P/E ratio for CELL stock is -0.65

The 52-week high for CELL stock is $3.65. The current CELL stock price $undefined is 100.00% below its 52-week high

The 52-week low for CELL stock is $0.38. The current CELL stock price $undefined has increased 100.00% from its 52-week low

No, the CELL stock does not pay dividends to its shareholders

How to buy CELL stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in CELL stock

    Navigate to the Explore page. Then, type CELL into the search bar. When you see CELL stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased CELL stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

PhenomeX Inc Stock Earnings

The value each CELL share was expected to gain vs. the value that each CELL share actually gained.

PhenomeX Inc (CELL) reported Q2 2023 earnings per share (EPS) of -$0.33, missing estimates of -$0.32 by 3.13%. In the same quarter last year, PhenomeX Inc's earnings per share (EPS) was $0. PhenomeX Inc is expected to release next earnings on 08/14/2023, with an earnings per share (EPS) estimate of $0.

Buy PhenomeX Inc (CELL) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.